Close Menu

NEW YORK – Sera Prognostics has published new data demonstrating the effectiveness of its PreTRM test for predicting risk of preterm birth as it works to build out the clinical evidence supporting the assay.

Detailed last month in a paper published in the American Journal of Obstetrics and Gynecology, the results found that the PreTRM test was useful for identifying women at high risk of delivering prior to 32 weeks.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.